|
Desmopressin Rhinal Tube Nose Solution
|
|
DDAVP Rhinal Tube
|
Desmopressin Rhinal Tube Nose Solution Clinical Trials
- Desmopressin Response in the Young
ClinicalTrials.gov Identifier: NCT00230594 - Active, not recruiting
Primary Nocturnal Enuresis
- Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00003327 - Active, not recruiting
Nose Cancer; Oral Cancer
- A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
ClinicalTrials.gov Identifier: NCT00245479 - Active, not recruiting
Nocturnal Enuresis
- Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish Population
ClinicalTrials.gov Identifier: NCT00341068 - Active, not recruiting
Neural Tube Defects (NTDs); Facial Cleft Defect
- Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
ClinicalTrials.gov Identifier: NCT00004865 - Active, not recruiting
Nose Cancer; Oral Cancer; Throat Cancer
- Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00003385 - Active, not recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00005025 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00003582 - Active, not recruiting
Nose Cancer; Oral Cancer; Throat Cancer; Quality of Life
- Phase II Study in Patients with EGFR + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00063401 - Active, not recruiting
Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Neoplasms
- Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00022217 - Active, not recruiting
Nose Cancer; Oral Cancer; Throat Cancer
- PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
ClinicalTrials.gov Identifier: NCT00390598 - Active, not recruiting
Colonoscopy
- Desmopressin in Cardiac Surgery
ClinicalTrials.gov Identifier: NCT00337766 - Recruiting
Hemorrhage; Blood Loss, Surgical; Postoperative Hemorrhage
- Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
ClinicalTrials.gov Identifier: NCT00012090 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
ClinicalTrials.gov Identifier: NCT00477490 - Recruiting
Nocturia
- Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00002895 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00006041 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- OVCA-NAC-P2: Study of Chemotherapy followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers
ClinicalTrials.gov Identifier: NCT00112086 - Active, not recruiting
Ovarian Neoplasms; Fallopian Tube Neoplasms
- An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
ClinicalTrials.gov Identifier: NCT00191646 - Active, not recruiting
Genital Neoplasms, Female; Fallopian Tube Neoplasms; Ovarian Neoplasms; Pelvic Neoplasms; Peritoneal Neoplasms
- Topotecan and Gefitinib (Iressa) for Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00317772 - Active, not recruiting
Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Cancer
- Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00008138 - Active, not recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Combination Chemotherapy in Treating Women With Stage III Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003896 - Active, not recruiting
stage III ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00003777 - Active, not recruiting
Oral Cancer; Throat Cancer; Nose Cancer
- Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)
ClinicalTrials.gov Identifier: NCT00452829 - Recruiting
Recurrent Neural Tube Defects
- A Comparison of GV Mouth Washes,Nystatin,Ketoconazole Tabs in Treating Oropharyngeal Candidiasis
ClinicalTrials.gov Identifier: NCT00128323 - Active, not recruiting
Oropharyngeal candidiasis
- Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003560 - Active, not recruiting
Endometrial Cancer; Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00006391 - Active, not recruiting
recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00059787 - Active, not recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00550784 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00060359 - Active, not recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Treating Patients With Recurrent Late-Stage Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00091377 - Active, not recruiting
recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00217555 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Topotecan in Treating Patients With Progressive or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00287859 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00217529 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Study of Novel Types of Familial Diabetes Insipidus
ClinicalTrials.gov Identifier: NCT00004364 - Active, not recruiting
Diabetes Insipidus
- Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00354601 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Aspiration of Subglottic Secretions Using Hi-Lo Evac Endotracheal Tube: Tube Size and Incidence of Suction Lumen Dysfunction
ClinicalTrials.gov Identifier: NCT00450476 - Recruiting
Aspiration of Subglottic Secretions
- Examination of Double-Lumen Tube Placement by Functional Electrical Impedance Tomography
ClinicalTrials.gov Identifier: NCT00486616 - Recruiting
Double-Lumen Tube Placement; One-Lung Ventilation
- Cleaning of the Nose After Sinus Surgery: Necessary or Only Bothersome?
ClinicalTrials.gov Identifier: NCT00184392 - Active, not recruiting
Acute Recurrent Rhinosinusitis
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003064 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Phase II Study of Modified Triple Doublet Therapy in Women with Newly Diagnosed Mullerian Carcinoma
ClinicalTrials.gov Identifier: NCT00157560 - Active, not recruiting
Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
- CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00017017 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00028743 - Active, not recruiting
stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00547053 - Recruiting
Cystic Fibrosis
- Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00006942 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00053833 - Active, not recruiting
recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; ...
- Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00041080 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00126542 - Active, not recruiting
recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00031954 - Active, not recruiting
stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00021034 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
ClinicalTrials.gov Identifier: NCT00003634 - Active, not recruiting
Fallopian Tube Cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Quality of Life; peritoneal cavity cancer
- ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
ClinicalTrials.gov Identifier: NCT00407407 - Recruiting
Fallopian Tube Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms
- Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00004064 - Active, not recruiting
stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
- Protein Evaluation in Patients With Stage III or Stage IV Primary Peritoneal or Fallopian Tube Cancer or Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer in Remission
ClinicalTrials.gov Identifier: NCT00020033 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Chemosensitivity Assays in Predicting Response to Chemotherapy in Patients With Persistent, Refractory, or Recurrent Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00301717 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00003636 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- Accuracy of the ChemoFx Chemoresponse Assay in Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer.
ClinicalTrials.gov Identifier: NCT00288275 - Recruiting
Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Neoplasms
- Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00538031 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- GM-CSF and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin
ClinicalTrials.gov Identifier: NCT00466960 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00499252 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
ClinicalTrials.gov Identifier: NCT00305838 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Phase II Study of Weekly Topotecan With Bevacizumab in Platinum Resistant Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
ClinicalTrials.gov Identifier: NCT00343044 - Recruiting
Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
- Sirolimus to Prevent GVHD after Stem Cell Transplant for Blood Cancers
ClinicalTrials.gov Identifier: NCT00074490 - Recruiting
Hematologic Neoplasms; Neural Tube Defects; Myeloproliferative Disorders
- VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00436501 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
ClinicalTrials.gov Identifier: NCT00352300 - Recruiting
Fallopian Tube Cancer; Infection; Neutropenia; Ovarian Cancer; Peritoneal Cavity Cancer
- Sunitinib in Treating Patients With Advanced or Metastatic Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00388037 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Carboplatin and Paclitaxel With or Without Cediranib in Treating Women With Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00544973 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Carboplatin Plus Docetaxel and Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
ClinicalTrials.gov Identifier: NCT00085358 - Recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Tube Versus Trabeculectomy (TVT) Study
ClinicalTrials.gov Identifier: NCT00306852 - Active, not recruiting
Glaucoma
- Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00096200 - Recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- PXD101 in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors
ClinicalTrials.gov Identifier: NCT00301756 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00263822 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Bevacizumab and Docetaxel in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00504257 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Ixabepilone and Liposomal Doxorubicin in Treating Patients With Advanced Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00182767 - Recruiting
Breast Cancer; Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00373217 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- AZD2171 in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00278343 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00562640 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00079430 - Recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00045461 - Recruiting
Fallopian Tube Cancer; peritoneal cavity cancer; recurrent ovarian epithelial cancer
- Oxaliplatin and Topotecan in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00313612 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- BIBF 1120 in Treating Patients With Relapsed Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00370175 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00114166 - Recruiting
recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00275028 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Sorafenib and Bevacizumab in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer That is Recurrent or Did Not Respond to Previous Treatment
ClinicalTrials.gov Identifier: NCT00436215 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00483782 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00565851 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission
ClinicalTrials.gov Identifier: NCT00522301 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00303888 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00331422 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Denileukin Diftitox in Treating Patients With Advanced Refractory Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00357448 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- E7389 in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00334893 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Efficacy of Weekly Versus Daily Folic Acid Supplementation
ClinicalTrials.gov Identifier: NCT00394862 - Active, not recruiting
Neural Tube Defects
- Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer, Metastatic Breast Cancer, or Advanced Endometrial Cancer
ClinicalTrials.gov Identifier: NCT00245050 - Recruiting
Breast Cancer; Drug Toxicity; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
ClinicalTrials.gov Identifier: NCT00032162 - Active, not recruiting
Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; uterine sarcoma; ovarian sarcoma; ovarian carcinosarcoma
- Vandetanib in Treating Patients With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00445549 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00267696 - Recruiting
Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
- Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
ClinicalTrials.gov Identifier: NCT00582205 - Recruiting
Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Uterine Cancer
- Proteomic Profiling in Predicting Relapse in Patients with Stage III Or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, Or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00119353 - Recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Mastoid Bone Autograft for Dorsal Nasal Augmentation
ClinicalTrials.gov Identifier: NCT00545428 - Recruiting
Nose Deformities, Acquired
- Abraxane With Carboplatin in Ovarian, Peritoneal, or Fallopian Tube Cancer Patients
ClinicalTrials.gov Identifier: NCT00405223 - Recruiting
Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer
- Avastin and Erlotinib as First Line Consolidation Chemotherapy After CTA Induction Therapy for Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer & Papillary Serous Mullerian Tumors
ClinicalTrials.gov Identifier: NCT00520013 - Recruiting
Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; Papillary Serous Mullerian Cancer
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
